DK314487A - Benzoxepinderivat - Google Patents

Benzoxepinderivat

Info

Publication number
DK314487A
DK314487A DK314487A DK314487A DK314487A DK 314487 A DK314487 A DK 314487A DK 314487 A DK314487 A DK 314487A DK 314487 A DK314487 A DK 314487A DK 314487 A DK314487 A DK 314487A
Authority
DK
Denmark
Prior art keywords
derivatives
activity
benzoxepin
phenylbenzoxepin
plateles
Prior art date
Application number
DK314487A
Other languages
English (en)
Other versions
DK314487D0 (da
DK166676B1 (da
Inventor
Toshio Tatsuoka
Kayoko Nomura
Fumio Satoh
Takafumi Ishihara
Seiji Miyano
Kunihiro Sumoto
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of DK314487D0 publication Critical patent/DK314487D0/da
Publication of DK314487A publication Critical patent/DK314487A/da
Application granted granted Critical
Publication of DK166676B1 publication Critical patent/DK166676B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK314487A 1986-06-20 1987-06-19 2-phenoxybenzoxepinderivater, farmaceutisk praeparat indeholdende et saadant derivat, samt en fremgangsmaade til fremstilling af derivaterne DK166676B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14289886 1986-06-20
JP14289886 1986-06-20

Publications (3)

Publication Number Publication Date
DK314487D0 DK314487D0 (da) 1987-06-19
DK314487A true DK314487A (da) 1987-12-21
DK166676B1 DK166676B1 (da) 1993-06-28

Family

ID=15326163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK314487A DK166676B1 (da) 1986-06-20 1987-06-19 2-phenoxybenzoxepinderivater, farmaceutisk praeparat indeholdende et saadant derivat, samt en fremgangsmaade til fremstilling af derivaterne

Country Status (10)

Country Link
US (1) US4845094A (da)
EP (1) EP0250265B1 (da)
JP (1) JPH0813807B2 (da)
AT (1) ATE56211T1 (da)
AU (1) AU597671B2 (da)
CA (1) CA1277320C (da)
DE (1) DE3764724D1 (da)
DK (1) DK166676B1 (da)
ES (1) ES2017498B3 (da)
HU (1) HU206108B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use
JP2851054B2 (ja) * 1989-03-15 1999-01-27 サントリー株式会社 ベンズオキセピン誘導体
FR2698873B1 (fr) * 1992-12-07 1995-02-24 Lipha Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
ES2207652T3 (es) * 1994-08-05 2004-06-01 BAUSCH & LOMB INCORPORATED Dispositivo para la insercion de una lente intraocular flexible.
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6221897B1 (en) 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DK1140185T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
ATE240120T1 (de) 1998-12-23 2003-05-15 Searle Llc Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
WO2000038726A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
IL143949A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
EP1140190B1 (en) 1998-12-23 2002-11-20 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
HK1052183A1 (zh) 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
JP2005518347A (ja) 2001-11-02 2005-06-23 ジー．ディー． サール エルエルシー 頂端ナトリウム共依存性胆汁酸輸送（ａｓｂｔ）およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
BR0306643A (pt) 2002-01-17 2004-10-19 Pharmacia Corp Novos compostos de hidroxi alquil/aril ou ceto tiepina como inibidores do transporte co-dependente de ácido biliar-sódio apical
US20140323412A1 (en) 2011-10-28 2014-10-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
SG10201909122QA (en) 2011-10-28 2019-11-28 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
WO2016019587A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [7, 6]-fused bicyclic antidiabetic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593760A1 (de) * 1967-02-01 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Benz-epinderivate
DE2931399A1 (de) * 1979-08-02 1981-02-26 Kali Chemie Pharma Gmbh Neue 3-amino-1-benzoxepin-derivate und ihre salze, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3440295A1 (de) * 1984-11-05 1986-05-15 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur diastereoselektiven reduktion von 3-amino-1-benzoxepin-5(2h)-onen
US4736031A (en) * 1985-06-10 1988-04-05 Takeda Chemical Industries, Ltd. 2-(piperazinylalkyl)-1-benzothiepin, 1-benzoxepin, and 1,5-benzodioxepin derivatives

Also Published As

Publication number Publication date
ATE56211T1 (de) 1990-09-15
EP0250265B1 (en) 1990-09-05
ES2017498B3 (es) 1991-02-16
US4845094A (en) 1989-07-04
AU7424587A (en) 1987-12-24
HUT48231A (en) 1989-05-29
AU597671B2 (en) 1990-06-07
JPS63107972A (ja) 1988-05-12
EP0250265A1 (en) 1987-12-23
DK314487D0 (da) 1987-06-19
DE3764724D1 (de) 1990-10-11
HU206108B (en) 1992-08-28
DK166676B1 (da) 1993-06-28
CA1277320C (en) 1990-12-04
JPH0813807B2 (ja) 1996-02-14

Similar Documents

Publication Publication Date Title
DK314487D0 (da) Benzoxepinderivat
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
FI921087A0 (fi) Nya estrar av tienylkarboxylsyror och aminoalkoholer, deras kvaterniseringsprodukter och framstaellning och anvaendning av naemnda foereningar.
NO875487D0 (no) Fremgangsmaate for selektiv behandling av en undergrunnsformasjon.
FI871492A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
NO870890L (no) FremgangsmŸte for fremstilling av aromatiske 2-aminoalkyl-1,2-benzoisothiazol-3-(2h)-on-1,1-dioxyd-derivater.
AU577928B2 (en) Labd-14-en-11-one derivatives
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
KR900004003B1 (en) Antineo plastic substance and pharmaceutical composition thereof
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
NO871939L (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
DE3870723D1 (de) Herstellung von ascorbinsaeure-6-estern.
DE68909125D1 (de) Selektive Herstellung von 2,6-Diäthylnaphthalin.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
DE3786562D1 (de) 2,6-dideoxy-2-fluoro-l-talopyranose, derivate davon und herstellung dieser verbindungen.
FI883759A0 (fi) C.12-modifierade etromycin a-derivat.
FI93454B (fi) Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi
NO885200D0 (no) FremgangsmŸte for fremstilling av pro-legemidler.
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
GR3003638T3 (da)
DE68907733D1 (de) Herstellung von duesen.